Karen M. Hajra, Ph.D. - Publications
Affiliations: | 2004 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Molecular Biology, Genetics, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2002 | Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes, Chromosomes & Cancer. 34: 255-68. PMID 12007186 DOI: 10.1002/Gcc.10083 | 0.607 | |||
2002 | Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Research. 62: 1613-8. PMID 11912130 | 0.625 | |||
2000 | Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR, Fearon ER. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes & Development. 14: 1319-31. PMID 10837025 | 0.536 | |||
2000 | Hosono S, Gross I, English MA, Hajra KM, Fearon ER, Licht JD. E-cadherin is a WT1 target gene. The Journal of Biological Chemistry. 275: 10943-53. PMID 10753894 DOI: 10.1074/Jbc.275.15.10943 | 0.578 | |||
2000 | Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR, Fearon ER. γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin Genes & Development. 14: 1319-1331. DOI: 10.1101/Gad.14.11.1319 | 0.531 | |||
1999 | Hajra KM, Ji X, Fearon ER. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene. 18: 7274-9. PMID 10602481 DOI: 10.1038/Sj.Onc.1203336 | 0.599 | |||
Show low-probability matches. |